rxstatShortages › Methocarbamol Codeine Acetylsalicylic Acid

Methocarbamol Codeine Acetylsalicylic Acid shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Methocarbamol Codeine Acetylsalicylic Acid is in a widespread shortage in Canada. 4 of 5 reported products are affected. The latest manufacturer estimate for full recovery is Oct 10, 2022.
Products affected
4 of 5
In shortage since
Mar 1, 2013
Est. full return
Oct 10, 2022
Reports on file
7
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
ROBAXISAL C 1/2
32.4MG 400MG 325MG · TABLET · GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN 01934791 · since ?, est. end Oct 10, 2022 · Disruption of the manufacture of the drug.
Active shortage
METHOXISAL-C 1/2
325MG 400MG 32.4MG · TABLET · TEVA CANADA LIMITED
DIN 01966375 · since Mar 1, 2013, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
METHOXISAL-C 1/2
325MG 400MG 32.4MG · TABLET · TEVA CANADA LIMITED
DIN 01966375 · since Dec 1, 2013, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
METHOXISAL-C 1/4
325MG 400MG 16.2MG · TABLET · TEVA CANADA LIMITED
DIN 01966367 · since Dec 1, 2013, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
METHOXISAL-C 1/8
325MG 400MG 8MG · TABLET · TEVA CANADA LIMITED
DIN 01941895 · since Dec 1, 2013, no end estimate · Requirements related to complying with good manufacturing practices.
Discontinued
ROBAXISAL C 1/4
400MG 16.2MG 325MG · TABLET · GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN 01934783
Discontinued
ROBAXISAL C 1/2
325MG 32.4MG 400MG · TABLET · GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
DIN 01934791

What's happening

Methocarbamol Codeine Acetylsalicylic Acid is currently affected by 4 active shortage reports filed with Health Canada by GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC, TEVA CANADA LIMITED.

The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Methocarbamol Codeine Acetylsalicylic Acid is classified under “OPIOIDS” (ATC N02AA).

Recent changes

Common questions

When will Methocarbamol Codeine Acetylsalicylic Acid be back in stock in Canada?

The latest manufacturer estimate is Oct 10, 2022. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Methocarbamol Codeine Acetylsalicylic Acid in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (opioids)

All opioids shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.